EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to EMD Serono
Related studies linked through entity extraction aliases.
Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
- Status
- TERMINATED
- Phase
- PHASE3
Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)
- Status
- TERMINATED
- Phase
- PHASE2
Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)
- Status
- COMPLETED
- Phase
- N/A
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART)
- Status
- COMPLETED
- Phase
- N/A
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies
- Status
- COMPLETED
- Phase
- PHASE3
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
- Status
- COMPLETED
- Phase
- PHASE4
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment
- Status
- COMPLETED
- Phase
- N/A
EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study
- Status
- COMPLETED
- Phase
- PHASE3
r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial
- Status
- COMPLETED
- Phase
- PHASE1
The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial
- Status
- COMPLETED
- Phase
- PHASE4
Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials
- Status
- COMPLETED
- Phase
- N/A